Hemophilia A Gene Therapy - Some Answers, More Questions.
Lindsey A George et al. The New England journal of medicine 2023 2 (8) 761-763
Access to gene therapy for rare diseases when commercialization is not fit for purpose.
Thomas Fox et al. Nature medicine 2023 2
Perspectives on Evolving Gene Therapy for X-Linked Retinitis Pigmentosa.
Sabyasachi Sengupta et al. JAMA ophthalmology 2023 2
What It’s Like to Learn You’re Going to Live Longer Than You Expected
DJ Lamas, NY Times, February 6, 2023
Search Result Summary
- CDC Information (0)
- NIH Information (10)
- CDC Publications (2)
- COVID-19 (96)
- Human Genome Epidemiologic Studies (197)
- GWAS Studies (0)
- Genomics Precision Health (636)
- Non-Genomics Precision Health (0)
- Pathogen Advanced Molecular Detection (6)
- Hot Topics Archive (236)
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 27, 2023
- Content source: